What is what?
A series of blog about how stuff works in the financial markets.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Market Analysis
A view of the market through the lens of fundamental and technical analysis and predictions.
Domestic pharma giants– Cipla, Hetero got DCGI’s nod to manufacture, sell anti-viral Remdesivir drug to fight COVID ANI News
New Delhi [India], June 21 (ANI): In a significant development, India's top drug regulator has given nod to two domestic pharmaceutical companies--Cipla and Hetero for marketing authorization of anti-viral drug Remdesivir only for "restricted emergency use" o? Read...
read moreUS revokes emergency use of malaria drugs to treat Covid The Indian Express
Citing reports of heart complications, the FDA said the drugs pose a greater risk to patients than any potential benefits. Read More reported by AP at The Indian...
read moreIndia’s forex reserves jump $8.22 billion; cross halftrillion mark for first time – The Indian Express
In the previous week ended May 29, the forex reserves had increased by USD 3.44 billion to USD 493.48 billion. Read More reported by Express Web Desk at The Indian...
read more